International Chemical Investors is a privately owned industrial group with sales in excess of € 2 billion and more than 6,000 employees worldwide. ICIG is focusing on three main platforms: Pharmaceuticals under the CordenPharma brand, Fine Chemicals under the WeylChem brand and Chlorovinyls under the VYNOVA brand. Since inception in 2004, ICIG has acquired 25 independent chemicals and pharmaceutical businesses in Europe and the United States, all of which have origins in major global chemical or pharmaceutical corporations.
Our focus is exclusively on the chemicals and pharmaceutical industries, preferably subsidiaries of large corporations operating in competitive environments, which were considered non-core.
Our operating plants are well invested in favorable locations with an international orientation and leading positions in niche markets. ICIG companies presently employ 6,000 employees and operate 29 manufacturing plants, ten in Germany, five in Italy, four in France, three in the United States, two in Belgium, two in the United Kingdom, one in Poland, one in Switzerland and one in the Netherlands. The Group has sales or research and development offices in Germany, the United States, Switzerland, France, Italy, the United Kingdom, Finland, Russia and China.
ICIG values experience and outstanding research and development capabilities in its employees. Most of our company's management and employees were well trained in major corporations.
ICIG is focusing on three main platforms: Pharmaceutical under the CordenPharma brand, Fine Chemicals under the WeylChem brand and Chlorovinyls under the VYNOVA brand.